·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆÊ½ºÅ¸Å¬·´TVÆÊµµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ "¹ú·¹ ¹°·ÈÀ» ¶© µÕ±Ù¸Ó¸®" Çö´ë¾àǰ, ¹ö¹°¸® TV ±¤°í ±â»çÀÔ·Â : 21.05.17 09:22:46 0 °¡ ÇÃÄ£Ãß°¡ TVCF ¿Â¿¡¾î¡¦'±ÜÁö ¸»°í ¹Ù¸£¶ó' ¸Þ½ÃÁö Àü´Þ AD 11¿ù 2ÁÖÂ÷ ¸ÅÃ⠺м®ÀÌ ÇÊ¿äÇϸé? BRPInsight [µ¥Àϸ®ÆÊ=À̼®ÁØ ±âÀÚ] Çö´ë¾àǰÀÌ ¹ú·¹¹°¸²Ä¡·áÁ¦ '¹ö¹°¸®' TV ±¤°í¸¦ ½ÃÀÛÇß´Ù. Çö´ë¾àǰÀº Ä·ÇÎ µî ¾ß¿Ü Ȱµ¿ÀÌ Áõ°¡ÇÏ°í ¹ú·¹ ¹°¸² ¶ÇÇÑ ºó¹øÇØÁö´Â ½Ã±â¸¦ ¸Â¾Æ °£ÆíÇÏ°Ô ¹ú·¹ ¹°¸²¿¡ ´ëóÇÒ ¼ö ÀÖ´Â Á¦Ç° ¹ö¹°¸® TVCF¸¦ ¼±º¸¿´´Ù°í 17ÀÏ ¹àÇû´Ù. TVCF ¿µ»óÀº 'µÕ±Ù ¸Ó¸®'¸¦ °Á¶ÇÏ´Â ¹ö¹°¸®¼Û°ú ÇÔ²² ¹ö¹°¸® ¿äÁ¤ÀÌ ³ªÅ¸³ª ³²³à³ë¼Ò ´©±¸³ª ½Ç³» ¶Ç´Â ¾ß¿Ü¿¡¼ ¹ú·¹¿¡ ¹°·ÈÀ» ¶§ '±ÜÁö ¸»°í ¹Ù¸£¶ó'´Â ¸Þ½ÃÁö¸¦ Àü´ÞÇÑ´Ù. °£´ÜÇÑ ºÎÂø¸¸À¸·Î ¹ú·¹ ¹°¸²À» Ä¡·áÇÒ ¼ö ÀÖ´Â '¹ö¹°¸® Çöó½ºÅ¸'µµ ¼Ò°³Çß´Ù. Çö´ë¾àǰ ¹ö¹°¸®´Â '¹ö¹°¸® ¿¡½º¾×'À» ºñ·ÔÇØ Èí¼ö°¡ ºü¸¥ °Ö ŸÀÔ 'µÕ±Ù¸Ó¸® ¹ö¹°¸®°Ö', ¿¬¾àÇÑ ÇǺθ¦ À§ÇÑ 'µÕ±Ù¸Ó¸® ¹ö¹°¸® ۵åÅ©¸²', ÆÐÄ¡ ŸÀÔ '¹ö¹°¸® Çöó½ºÅ¸', »Ñ¸®´Â ŸÀÔ '¹ö¹°¸® ¾ËÆÄ¾×' µî ´Ù¾çÇÑ Á¦Ç°±ºÀ» °®Ãß°í ÀÖ´Ù. X AD NEW POSM ½Åû À̺¥Æ®Âü¿© ¡æ À̼®ÁØ ±âÀÚ(wiviwivi@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç [±âÀå Àå¾È] º¹»ê³ªÀ̽º °ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â JW 2025³â 5Â÷ ¼ö½Ãä¿ë ¹Ù·Î°¡±â ȯÀÎÁ¦¾à(ÁÖ) 11¿ù ¼ö½Ãä¿ë(11/30(ÀÏ) 23:59±îÁö) ¹Ù·Î°¡±â ÇØÅÂhtb ÀÍ»ê°øÀå °ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â Á¦Á¦¿¬±¸´ã´ç °æ·Â 5³â¡è(°ú~Â÷Àå±Þ) ä¿ë ¹Ù·Î°¡±â Çâ³²&¾È¼º Á¦Á¶°ü¸® ¾à»ç ä¿ë(½ÅÀÔ¿ì´ë) ¹Ù·Î°¡±â [´ë¿õÁ¦¾à] 2026 »ó¡¤ÇϹݱ⠾à´ë½ÉȽǽÀ ¸ðÁý ¹Ù·Î°¡±â [Çѱ¹¿ÀÃ÷Ä«Á¦¾à] Á¤±ÔÁ÷ °æ·Â CQM ä¿ë ¹Ù·Î°¡±â °³¹ßº»ºÎ ±âȹ, RA ÆÀÀå±Þ ä¿ë(°æ·Â 10³â¡è) ¹Ù·Î°¡±â Clinical Research Associate (CRA) ¹Ù·Î°¡±â °æ·Â Á¦¾à ÇØ¿Ü¸¶ÄÉÆÃ (ÀÎÇã°¡ ´ã´ç) ä¿ë ¹Ù·Î°¡±â 2025³â Á¦5Â÷ Á÷¿øÃ¤¿ë °ø°í ¹Ù·Î°¡±â Regulatory & Product Operation ¹Ù·Î°¡±â Çâ³²°øÀå OQA ǰÁú°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â Regulatory Execution Hub Sr. Associate ¹Ù·Î°¡±â [Çѵ¶] ½ÅÀÔ ¹× °æ·Â Á÷¹«º° ¼ö½Ãä¿ë (¸¶°¨ÀÏ Á÷¹«º° »óÀÌ) ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ¹ú·¹ ¹°·ÈÀ» ¶© µÕ±Ù¸Ó¸® Çö´ë¾àǰ, ¹ö¹°¸® TV ±¤°í URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ "¹ú·¹ ¹°·ÈÀ» ¶© µÕ±Ù¸Ó¸®" Çö´ë¾àǰ, ¹ö¹°¸® TV ±¤°í ±â»çÀÔ·Â : 21.05.17 09:22:46 0 °¡ ÇÃÄ£Ãß°¡ TVCF ¿Â¿¡¾î¡¦'±ÜÁö ¸»°í ¹Ù¸£¶ó' ¸Þ½ÃÁö Àü´Þ AD 11¿ù 2ÁÖÂ÷ ¸ÅÃ⠺м®ÀÌ ÇÊ¿äÇϸé? BRPInsight [µ¥Àϸ®ÆÊ=À̼®ÁØ ±âÀÚ] Çö´ë¾àǰÀÌ ¹ú·¹¹°¸²Ä¡·áÁ¦ '¹ö¹°¸®' TV ±¤°í¸¦ ½ÃÀÛÇß´Ù. Çö´ë¾àǰÀº Ä·ÇÎ µî ¾ß¿Ü Ȱµ¿ÀÌ Áõ°¡ÇÏ°í ¹ú·¹ ¹°¸² ¶ÇÇÑ ºó¹øÇØÁö´Â ½Ã±â¸¦ ¸Â¾Æ °£ÆíÇÏ°Ô ¹ú·¹ ¹°¸²¿¡ ´ëóÇÒ ¼ö ÀÖ´Â Á¦Ç° ¹ö¹°¸® TVCF¸¦ ¼±º¸¿´´Ù°í 17ÀÏ ¹àÇû´Ù. TVCF ¿µ»óÀº 'µÕ±Ù ¸Ó¸®'¸¦ °Á¶ÇÏ´Â ¹ö¹°¸®¼Û°ú ÇÔ²² ¹ö¹°¸® ¿äÁ¤ÀÌ ³ªÅ¸³ª ³²³à³ë¼Ò ´©±¸³ª ½Ç³» ¶Ç´Â ¾ß¿Ü¿¡¼ ¹ú·¹¿¡ ¹°·ÈÀ» ¶§ '±ÜÁö ¸»°í ¹Ù¸£¶ó'´Â ¸Þ½ÃÁö¸¦ Àü´ÞÇÑ´Ù. °£´ÜÇÑ ºÎÂø¸¸À¸·Î ¹ú·¹ ¹°¸²À» Ä¡·áÇÒ ¼ö ÀÖ´Â '¹ö¹°¸® Çöó½ºÅ¸'µµ ¼Ò°³Çß´Ù. Çö´ë¾àǰ ¹ö¹°¸®´Â '¹ö¹°¸® ¿¡½º¾×'À» ºñ·ÔÇØ Èí¼ö°¡ ºü¸¥ °Ö ŸÀÔ 'µÕ±Ù¸Ó¸® ¹ö¹°¸®°Ö', ¿¬¾àÇÑ ÇǺθ¦ À§ÇÑ 'µÕ±Ù¸Ó¸® ¹ö¹°¸® ۵åÅ©¸²', ÆÐÄ¡ ŸÀÔ '¹ö¹°¸® Çöó½ºÅ¸', »Ñ¸®´Â ŸÀÔ '¹ö¹°¸® ¾ËÆÄ¾×' µî ´Ù¾çÇÑ Á¦Ç°±ºÀ» °®Ãß°í ÀÖ´Ù. X AD NEW POSM ½Åû À̺¥Æ®Âü¿© ¡æ À̼®ÁØ ±âÀÚ(wiviwivi@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç [±âÀå Àå¾È] º¹»ê³ªÀ̽º °ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â JW 2025³â 5Â÷ ¼ö½Ãä¿ë ¹Ù·Î°¡±â ȯÀÎÁ¦¾à(ÁÖ) 11¿ù ¼ö½Ãä¿ë(11/30(ÀÏ) 23:59±îÁö) ¹Ù·Î°¡±â ÇØÅÂhtb ÀÍ»ê°øÀå °ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â Á¦Á¦¿¬±¸´ã´ç °æ·Â 5³â¡è(°ú~Â÷Àå±Þ) ä¿ë ¹Ù·Î°¡±â Çâ³²&¾È¼º Á¦Á¶°ü¸® ¾à»ç ä¿ë(½ÅÀÔ¿ì´ë) ¹Ù·Î°¡±â [´ë¿õÁ¦¾à] 2026 »ó¡¤ÇϹݱ⠾à´ë½ÉȽǽÀ ¸ðÁý ¹Ù·Î°¡±â [Çѱ¹¿ÀÃ÷Ä«Á¦¾à] Á¤±ÔÁ÷ °æ·Â CQM ä¿ë ¹Ù·Î°¡±â °³¹ßº»ºÎ ±âȹ, RA ÆÀÀå±Þ ä¿ë(°æ·Â 10³â¡è) ¹Ù·Î°¡±â Clinical Research Associate (CRA) ¹Ù·Î°¡±â °æ·Â Á¦¾à ÇØ¿Ü¸¶ÄÉÆÃ (ÀÎÇã°¡ ´ã´ç) ä¿ë ¹Ù·Î°¡±â 2025³â Á¦5Â÷ Á÷¿øÃ¤¿ë °ø°í ¹Ù·Î°¡±â Regulatory & Product Operation ¹Ù·Î°¡±â Çâ³²°øÀå OQA ǰÁú°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â Regulatory Execution Hub Sr. Associate ¹Ù·Î°¡±â [Çѵ¶] ½ÅÀÔ ¹× °æ·Â Á÷¹«º° ¼ö½Ãä¿ë (¸¶°¨ÀÏ Á÷¹«º° »óÀÌ) ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ¹ú·¹ ¹°·ÈÀ» ¶© µÕ±Ù¸Ó¸® Çö´ë¾àǰ, ¹ö¹°¸® TV ±¤°í URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ "¹ú·¹ ¹°·ÈÀ» ¶© µÕ±Ù¸Ó¸®" Çö´ë¾àǰ, ¹ö¹°¸® TV ±¤°í ±â»çÀÔ·Â : 21.05.17 09:22:46 0 °¡ ÇÃÄ£Ãß°¡ TVCF ¿Â¿¡¾î¡¦'±ÜÁö ¸»°í ¹Ù¸£¶ó' ¸Þ½ÃÁö Àü´Þ AD 11¿ù 2ÁÖÂ÷ ¸ÅÃ⠺м®ÀÌ ÇÊ¿äÇϸé? BRPInsight [µ¥Àϸ®ÆÊ=À̼®ÁØ ±âÀÚ] Çö´ë¾àǰÀÌ ¹ú·¹¹°¸²Ä¡·áÁ¦ '¹ö¹°¸®' TV ±¤°í¸¦ ½ÃÀÛÇß´Ù. Çö´ë¾àǰÀº Ä·ÇÎ µî ¾ß¿Ü Ȱµ¿ÀÌ Áõ°¡ÇÏ°í ¹ú·¹ ¹°¸² ¶ÇÇÑ ºó¹øÇØÁö´Â ½Ã±â¸¦ ¸Â¾Æ °£ÆíÇÏ°Ô ¹ú·¹ ¹°¸²¿¡ ´ëóÇÒ ¼ö ÀÖ´Â Á¦Ç° ¹ö¹°¸® TVCF¸¦ ¼±º¸¿´´Ù°í 17ÀÏ ¹àÇû´Ù. TVCF ¿µ»óÀº 'µÕ±Ù ¸Ó¸®'¸¦ °Á¶ÇÏ´Â ¹ö¹°¸®¼Û°ú ÇÔ²² ¹ö¹°¸® ¿äÁ¤ÀÌ ³ªÅ¸³ª ³²³à³ë¼Ò ´©±¸³ª ½Ç³» ¶Ç´Â ¾ß¿Ü¿¡¼ ¹ú·¹¿¡ ¹°·ÈÀ» ¶§ '±ÜÁö ¸»°í ¹Ù¸£¶ó'´Â ¸Þ½ÃÁö¸¦ Àü´ÞÇÑ´Ù. °£´ÜÇÑ ºÎÂø¸¸À¸·Î ¹ú·¹ ¹°¸²À» Ä¡·áÇÒ ¼ö ÀÖ´Â '¹ö¹°¸® Çöó½ºÅ¸'µµ ¼Ò°³Çß´Ù. Çö´ë¾àǰ ¹ö¹°¸®´Â '¹ö¹°¸® ¿¡½º¾×'À» ºñ·ÔÇØ Èí¼ö°¡ ºü¸¥ °Ö ŸÀÔ 'µÕ±Ù¸Ó¸® ¹ö¹°¸®°Ö', ¿¬¾àÇÑ ÇǺθ¦ À§ÇÑ 'µÕ±Ù¸Ó¸® ¹ö¹°¸® ۵åÅ©¸²', ÆÐÄ¡ ŸÀÔ '¹ö¹°¸® Çöó½ºÅ¸', »Ñ¸®´Â ŸÀÔ '¹ö¹°¸® ¾ËÆÄ¾×' µî ´Ù¾çÇÑ Á¦Ç°±ºÀ» °®Ãß°í ÀÖ´Ù. X AD NEW POSM ½Åû À̺¥Æ®Âü¿© ¡æ À̼®ÁØ ±âÀÚ(wiviwivi@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ¹ú·¹ ¹°·ÈÀ» ¶© µÕ±Ù¸Ó¸® Çö´ë¾àǰ, ¹ö¹°¸® TV ±¤°í URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö